Cargando…
Smoflipid Is Better Than Lipofundin for Long-Term Neurodevelopmental Outcomes in Preterm Infants
Neurodevelopmental morbidities developed more commonly in low-birth-weight premature infants. We sought to determine the effects of different lipid emulsions on the neurodevelopmental outcomes of children born prematurely. This retrospective cross-sectional study had two intervention legs, Lipofundi...
Autores principales: | Chen, I-Lun, Hung, Chih-Hsing, Huang, Hsin-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398319/ https://www.ncbi.nlm.nih.gov/pubmed/34444708 http://dx.doi.org/10.3390/nu13082548 |
Ejemplares similares
-
SMOFlipid Impact on Growth and Neonatal Morbidities in Very Preterm Infants
por: Asfour, Suzan S., et al.
Publicado: (2022) -
Comparative study of the safety and efficacy of SMOFlipid vs non SMOFlipid as TPN for liver transplantation
por: Wu, Mei-Yun, et al.
Publicado: (2021) -
Effects of Fish Oil (SMOFlipid(®)) and Olive Oil Lipid (ClinOleic(®)) on Neonatal Morbidities in Preterm Infants
por: KILICBAY, Fatih, et al.
Publicado: (2022) -
Long‐term neurodevelopmental outcome in preterm infants with intraventricular haemorrhage
por: Legge, Nele, et al.
Publicado: (2022) -
Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2022)